Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02049320 · ClinicalTrials.gov registry record
Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)
A clinical trial, sponsored by Joseph D. Tobias.
- Completed
- Registry status
- 38
- Enrollment target
NCT02049320 is a clinical trial that has completed, run by Joseph D. Tobias. The registered enrollment target is 38 participants.
The verdict
NCT02049320 has completed, sponsored by Joseph D. Tobias.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
This is a descriptive retrospective study designed to measure the efficacy of remifentanil sedation and the ability to perform frequent neurological examinations of patients with traumatic brain injuries.
Interventions
- DRUG Remifentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02049320
The ClinicalTrials.gov registry entry for NCT02049320 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joseph D. Tobias, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Remifentanil is the first listed.
NCT02049320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02049320 about?
NCT02049320 is a clinical study titled "Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)". This is a descriptive retrospective study designed to measure the efficacy of remifentanil sedation and the ability to perform frequent neurological examinations of patients with traumatic brain injuries.
What is the current status of trial NCT02049320?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2013-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02049320?
The interventions under investigation include: Remifentanil (DRUG).
Who is sponsoring clinical trial NCT02049320?
This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.